The Motley Fool

Why Bravura, Clinuvel, CSR, & Medibank shares tumbled lower today

The S&P/ASX 200 index has followed the lead of U.S. markets and dropped lower on Wednesday. In afternoon trade the benchmark index is down 0.6% to 6,532 points.

Four shares that have fallen more than most today are listed below. Here’s why they have tumbled lower:

The Bravura Solutions Ltd (ASX: BVS) share price has dropped 4% to $4.57 despite there being no news out of the fintech company. But with the technology-focused Nasdaq index dropping notably lower overnight, a number of Australian tech shares have come under pressure today. I feel this could be a buying opportunity for investors willing to make a patient long term investment.

The Clinuvel Pharmaceuticals Limited (ASX: CUV) share price has fallen 4.5% to $25.18. A small portion of this decline is related to the biopharmaceutical company’s shares trading ex-dividend this morning. The remainder is likely to be down to profit taking from investors after a very impressive share price gain in 2019. Prior to today the company’s shares had more than doubled in value since the turn of the year.

The CSR Limited (ASX: CSR) share price has crashed over 7% lower to $3.68. The catalyst for this decline appears to be a bearish broker note relating to the building products company. According to a note out of Ord Minnett, its analysts have downgraded its shares to a lighten rating and cut the price target on them to $3.50. This was largely down to a reduction in its forecasts for building product margins and property earnings.

The Medibank Private Ltd (ASX: MPL) share price is down 4% to $3.39. A good portion of today’s decline is attributable to the private health insurer’s shares trading ex-dividend this morning for its final and special dividends totalling 9.9 cents per share. These dividends will now be paid to eligible shareholders on September 26. In addition to this, on Tuesday its shares came under pressure after the ACCC sued it for misleading policyholders and incorrectly rejecting claims.

Our Top 3 Blue Chip Shares for 2019 – NOW AVAILABLE!

You’re invited! For a limited time, The Motley Fool Australia is giving away an urgent new investment report detailing our 3 TOP BLUE CHIP SHARES to own in 2019.

So if you like trustworthy, stable, high-performing companies that pay fat fully franked dividends – we’ve got you covered!

Stock #1 is a beloved old Australian company turning its attention to high-margin businesses... and rapidly returning cash to shareholders with its hefty dividend...

While Stock #2 is an online powerhouse that’s rapidly gaining market share all around the globe... poised for years (or even decades) of tremendous growth...

Even better, Stock #3 offers a whopping 6.5% grossed-up dividend! Which beats the rates on term deposits right out of the water – and offers the potential for capital gains, too.

You can discover all three shares inside our new report right now. To scoop up your FREE copy, simply click the link below right now. But you will want to hurry – this free report is available for a LIMITED TIME ONLY!


Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Bravura Solutions Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

FREE REPORT: Five Cheap and Good Stocks to Buy now…

Our Motley Fool experts have FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.